Mark Linthicum and Jennifer Bright, both with the Innovation and Value Initiative (IVI), say there’s a a need to better utilize value information for decision-making.
The Journal of Clinical Pathways (JCP) recently spoke with Linthicum and Bright about where IVI fits into that equation, and how it’s working to identify key areas where improvements can be made.
” … Our methods focus on involving patients at the beginning so that we can really understand how patients define factors of value in their treatment for a given disease,” Bright says.
Linthicum tells JCP says while there’s been increased interest focus on value assessments, decisions have to date lacked sufficient evidence and methods.
“Therefore, in addition to advancing the scientific methods, we also work to identify the places where the community of researchers and health care practitioners can focus their efforts to expand the available evidence,” he said.